Pharmacotherapy of apnoea-free sleep disorders in patients with metabolic syndrome
Aim. To evaluate the effectiveness and safety of zopiclone in apnoea-free sleep disorders among patients with metabolic syndrome (MS). Material and methods. The study included 60 patients with chronic cerebrovascular disease (CerVD) and MS (mean age 53,3±11,2 years). Zopiclone was administered in th...
Saved in:
| Main Authors: | O. V. Lyubshina, A. L. Vertkin, M. Yu. Maksimova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2010-04-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2042 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFECT OF FLUOXETINE ON SLEEP ARCHITECTURE IN PATIENTS WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA SYNDROME
by: O. V. Lyubshina, et al.
Published: (2016-01-01) -
Association Between Sleep Reactivity, Pre-Sleep Arousal State, and Neuroendocrine Hormones in Patients with Chronic Insomnia Disorder
by: Yu K, et al.
Published: (2024-12-01) -
Sleep disturbances in obese patients with arterial hypertension
by: O. V. Lubshina, et al.
Published: (2010-06-01) -
Sleep disorders in patients with multiple sclerosis
by: Ebrahim Kouchaki, et al.
Published: (2025-05-01) -
Obstructive Sleep Apnoea
by: B.M. Gardner
Published: (2014-09-01)